Response Tailored Protocol Versus the Fixed 12 Weeks Course of Dual Sofosbuvir/Daclatasvir Treatment in Egyptian Patients With Chronic Hepatitis C Genotype-4 Infection: A Randomize...

by Mostafa Yakoot, Alaa M. Abdo, Siham Abdel-Rehim, Sherine Helmy
Published 2017-07-01

Bioequivalent pharmacokinetics for generic and originator hepatitis C direct-acting antivirals

by Andrew Hill, Loai Tahat, Mohammed Khalil Mohammed, R.abab Fayez Tayyem, Giten Khwairakpam, Sanjay Nath, James Freeman, Ismahane Benbitour, Sherine Helmy
Published 2018-04-01